USA Compression Partners, LP (USAC) Might Be Poised For A Short Term Move

USA Compression Partners, LP (USAC) has seen some recent volatility in the marketplace and its stock closed trading at $11.57 yesterday. Investors are starting to take interest of USAC as the stock traded as high as $11.57 and as low as $11.12 in the prior market session.

USA Compression Partners, LP (USAC) average trading volume is 222.00K. However, in the prior market session USA Compression Partners, LP (USAC) traded 554,698 shares. The First support level on USAC is $11.48 and the First resistance level on USAC is $14.29. USAC 50day moving average is $10.75 and USAC 200day moving average is $10.73.

USA Compression Partners, LP (USAC) most current performance has been specified by the recent movement in USAC stock. USAC has performed 13.43% over the past month, USAC has performed -6.01% over the past 90 days and USAC has shown -35.65% over the past year. USA Compression Partners, LP (USAC) has a 1 year range of $3.52 to $18.32. USA Compression Partners, LP (USAC) is trading 228.69% from its 1 year low and -36.84% from its 1 year high. USA Compression Partners, LP (USAC) is displaying a 1.71% short float displaying the sum short in the float.

USAC has 96.78M shares outstanding and 49.63M shares in the float. USA Compression Partners, LP (USAC) presently has a market cap of $1.16B and income of -625.90M. The EPS next quarter for USAC is -0.08 and projected EPS next year is 96.80%. The market cap of USA Compression Partners, LP (USAC) at $1.16B represents how many Investors own shares of USAC and is based off the last price ($11.57) of USAC and the sum of shares outstanding (96.78M) with USA Compression Partners, LP (USAC).

USA Compression Partners, LP (USAC) has aggregate cash (mrq) of 2k, aggregate cash per share (mrq) of 0, aggregate debt of USAC rests at 1.93B and aggregate debt/equity (mrq) is 206.05. . USA Compression Partners, LP (USAC) operating cash flow (ttm) is 300.43M, USAC leveraged free cash flow (ttm) is 164.58M.

USAC is trading 8.83% above (bullish) its SMA20, 4.98% above (bullish) its SMA50 and 2.50% above (bullish) its SMA200.

Related Articles

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Dada Group (NASDAQ: DADA) Extends Partnership With Lianhua Supermarket

Dada Group (NASDAQ: DADA) has disclosed that it has extended its strategic partnership with Lianhua Supermarket Holdings Co., Ltd. Both the companies aimed to focus...

Diana Shipping (NYSE: DSX) Signs Time Charter Contract With CLdN Cobelfret

Diana Shipping (NYSE: DSX) has revealed that it has signed a time charter contract with CLdN Cobelfret SA through its fully-owned unit. US$12,100 is...

Biogen (NASDAQ: BIIB) And Sage Therapeutics Inks Agreement To Develop Therapies For Depression

Biogen Inc. (NASDAQ: BIIB) and Sage Therapeutics, Inc. (NASDAQ: SAGE) communicated that they are partnering together and will be combining their efforts to develop...

BBVA And Sabadell Ends Talks Of A Merger Due To Conflict Over Price

Banco Bilbao Vizcaya Argentaria S.A. (NYSE: BBVA) and Banco de Sabadell SA have discussed the terms of a merger but the negotiation turned out...

Hancock Jaffe (NASDAQ: HJLI) Confirms 1:25 Reverse Stock Split

Hancock Jaffe Laboratories, Inc. (NASDAQ: HJLI), a company that manufactures medical devices used to treat heart problems, publicized that its Board of Directors has...